ANIK Long Call Strategy

ANIK (Anika Therapeutics, Inc.), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.

ANIK (Anika Therapeutics, Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $196.9M, a beta of 0.16 versus the broader market, a 52-week range of 7.87-16.24, average daily share volume of 137K, a public-listing history dating back to 1993, approximately 288 full-time employees. These structural characteristics shape how ANIK stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.16 indicates ANIK has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a long call on ANIK?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current ANIK snapshot

As of May 15, 2026, spot at $14.88, ATM IV 70.80%, IV rank 11.34%, expected move 20.30%. The long call on ANIK below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long call structure on ANIK specifically: ANIK IV at 70.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a ANIK long call, with a market-implied 1-standard-deviation move of approximately 20.30% (roughly $3.02 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ANIK expiries trade a higher absolute premium for lower per-day decay. Position sizing on ANIK should anchor to the underlying notional of $14.88 per share and to the trader's directional view on ANIK stock.

ANIK long call setup

The ANIK long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ANIK near $14.88, the first option leg uses a $14.88 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ANIK chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ANIK shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$14.88N/A

ANIK long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

ANIK long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on ANIK. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on ANIK

Long calls on ANIK express a bullish thesis with defined risk; traders use them ahead of ANIK catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

ANIK thesis for this long call

The market-implied 1-standard-deviation range for ANIK extends from approximately $11.86 on the downside to $17.90 on the upside. A ANIK long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current ANIK IV rank near 11.34% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on ANIK at 70.80%. As a Healthcare name, ANIK options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ANIK-specific events.

ANIK long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ANIK positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ANIK alongside the broader basket even when ANIK-specific fundamentals are unchanged. Long-premium structures like a long call on ANIK are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current ANIK chain quotes before placing a trade.

Frequently asked questions

What is a long call on ANIK?
A long call on ANIK is the long call strategy applied to ANIK (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With ANIK stock trading near $14.88, the strikes shown on this page are snapped to the nearest listed ANIK chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are ANIK long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the ANIK long call priced from the end-of-day chain at a 30-day expiry (ATM IV 70.80%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a ANIK long call?
The breakeven for the ANIK long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ANIK market-implied 1-standard-deviation expected move is approximately 20.30%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on ANIK?
Long calls on ANIK express a bullish thesis with defined risk; traders use them ahead of ANIK catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current ANIK implied volatility affect this long call?
ANIK ATM IV is at 70.80% with IV rank near 11.34%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related ANIK analysis